DNA adduct formation of the aromatic amine, 4-aminobiphenyl (4-ABP), a known human carcinogen present in tobacco smoke, and the heterocyclic aromatic amines (HAAs), 2-amino-9H-pyrido [2,3-b]indole (AαC), 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP), 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), and 2-amino-3,8-dimethylmidazo[4,5-f]quinoxaline (MeIQx), potential human carcinogens, which are also present in tobacco smoke or formed during the hightemperature cooking of meats, was investigated in freshly cultured human hepatocytes. The carcinogens (10 μM) were incubated with hepatocytes derived from eight different donors for time periods up to 24 h. The DNA adducts were quantified by liquid chromatography-electrospray ionization mass spectrometry with a linear quadrupole ion trap mass spectrometer. The principal DNA adducts formed for all of the carcinogens were N-(deoxyguanosin-8-yl) (dG-C8) adducts. The levels of adducts ranged from 3.4 to 140 adducts per 10 7 DNA bases. The highest level of adduct formation occurred with AαC, followed by 4-ABP, then by PhIP, MeIQx, and IQ. Human hepatocytes formed dG-C8-HAA-adducts at levels that were up to 100-fold greater than the amounts of adducts produced in rat hepatocytes. In contrast to HAA adducts, the levels of dG-C8-4-ABP adduct formation were similar in human and rat hepatocytes. These DNA binding data demonstrate that the rat, an animal model that is used for carcinogenesis bioassays, significantly underestimates the potential hepatic genotoxicity of HAAs in humans. The high level of DNA adducts formed by AαC, a carcinogen produced in tobacco smoke at levels that are up to 100-fold higher than the amounts of 4-ABP, is noteworthy. The possible causal role of AαC in tobaccoassociated cancers warrants investigation.
INTRODUCTION
4-Aminobiphenyl (4-ABP) is a prototypical aromatic amine and a recognized human urinary bladder carcinogen (1-3). 4-ABP served as an antioxidant in the rubber industry prior to discovery of its carcinogenic activity (2, 3) . In the United States and many developed countries, strict federal regulations have drastically diminished the industrial usage of 4-ABP and other carcinogenic aromatic amines, but 4-ABP can still be found as a contaminant in color additives (4, 5) , paints (6) , food colors (7), leather and textile dyes (8, 9) . 4-ABP and other aromatic amines also arise in diesel-exhaust particles (10) (11) (12) and cooking oil fumes (13) . A major source of exposure to 4-ABP occurs through tobacco smoke: 4-ABP is present in mainstream tobacco smoke at levels ranging from 0.1 to 4.3 ng/cigarette (14, 15) Another potential source of exposure to 4-ABP occurs through the usage of commercial hair dyes (16, 17) .
Heterocyclic aromatic amines (HAAs) are carcinogens in experimental laboratory animals and potential human carcinogens (18) . HAAs are structurally related to aromatic amines: both classes of compounds undergo common pathways of bioactivation (19, 20) . The principal source of exposure to HAAs occurs through consumption of well-done cooked meats: the concentrations of HAAs can range from <1 part-per-billion up to the 500 ppb level (18, 21, 22) . Several HAAs are also formed during the high-temperature burning of tobacco. 2-Amino-9H-pyrido [2,3-b] indole (AαC) was one of the first chemicals in a series of HAAs identified in protein pyrolysates (23, 24) . Thereafter, AαC was detected in mainstream tobacco smoke at levels ranging from 60 to 258 ng/cigarette (25, 26) . These levels are ~25 to 100-fold higher than the levels of 4-ABP, 2-naphthylamine, or benzo(a)pyrene (27) present in mainstream smoke and are comparable to the levels of tobacco specific nitrosamines, such as 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (28) . The latter compounds are known human carcinogens. 2-Amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP) occurs in mainstream tobacco smoke at levels that range from 11 to 23 ng/cigarette (29) . PhIP also forms during the combustion of organic material, and it is present in air-borne and diesel exhaust particles (12) . 2-Amino-3-methylimidazo [4,5- f]quinoline (IQ) was reported at levels below 1 ng/cigarette (30) , whereas 2-amino-3,8-dimethylimidazo [4,5- f]quinoxaline (MeIQx) was not detected. Thus, there is much concern about the health risk associated with the exposure to these structurally related class of chemicals found in tobacco smoke and cooked meats.
One approach that has been used to assess the carcinogenic potential of genotoxic chemicals is the carcinogen binding index (31) . This approach has been used in rodent models, where the DNA adduct levels of carcinogens measured in liver at the given dose are normalized to the dose which resulted in a 50% tumor incidence under the conditions of a 2-year bioassay (TD 50 dose). The carcinogen binding index has been used as a preliminary assessment of the carcinogenic potential of a chemical (31) ; however, the development of cancer is a multifactorial process, that requires a number of steps, including mutations, genetic alterations, and cell proliferation (18) . Moreover, the extrapolation of animal carcinogenicity data to assess human health risk has many uncertainties, which can lead to tenuous risk assessment estimates. Perhaps the most critical and variable parameters in interspecies extrapolation are the effects of dose, species differences in catalytic activities of xenobiotic metabolism enzymes, and the influence of genetic polymorphisms that encode enzymes that lead to interindividual differences in metabolism of carcinogens (32) .
The liver is the most metabolically active organ in the biotransformation of 4-ABP and HAAs to genotoxic metabolites (33, 34) . We have previously shown that freshly isolated human hepatocytes in primary culture effectively metabolize a variety of chemical carcinogens (35) , including aflatoxin B 1 (36) , MeIQx (37) , and PhIP (38) to reactive metabolites capable of damaging DNA. In this study, we have investigated the capacity of human and rat hepatocytes to bioactivate 4-ABP and several HAAs, to form DNA adducts, which are believed to be the initiating events of chemical carcinogenesis (39) . Our data show that HAAs covalently bind to DNA in human hepatocytes at considerable levels.
Moreover, the levels of AαC adducts formed are comparable to the levels of DNA adducts formed with 4-ABP, a known human carcinogen. The amounts of HAA-DNA adducts formed in human hepatocytes are much greater than the levels of adducts produced in hepatocytes of rats, a species that is used in long-term carcinogen bioassays and extrapolation of toxicity data for human risk assessment. Thus, the data on the carcinogen binding index of HAAs in rat hepatocytes greatly underestimates the genotoxic potential of HAAs in human hepatocytes.
Materials and Methods

Caution
AαC, 4-ABP, IQ, MeIQx, PhIP are carcinogens, and they should only be handled in a wellventilated fume hood with the appropriate protective clothing. (16) . [ 13 C 10 ]-dG (99.9% isotopically pure) was purchased from Cambridge Isotopes (Andover, MA). Alkaline phosphatase (from E. coli), and nuclease P1 (from Penicillium citrinum) were purchased from Sigma (St. Louis, MO). Phosphodiesterase I (from Crotalus adamanteus venom) was from GE Healthcare (Piscataway, NJ). All solvents used were high-purity B & J Brand from Honeywell Burdick and Jackson (Muskegon, MI). ACS reagent-grade formic acid (88%) was purchased from J.T. Baker (Phillipsburg, NJ). HyperSep ™ filter SpinTips C18 (20 mg) were from Thermo Scientific (Palm Beach, FL). Oragene-DNA saliva kits were from Genotek Inc. (Ontario, Canada).
Chemicals
Preparation of MeIQx and PhIP metabolites
The following metabolites and their trideuterated internal standards were prepared by chemical means (37) or biosynthetically as previously reported (40): 2-Amino-3-methylimidazo [4,5- (42, 43) , and N-(deoxyguanosin-8-yl)-PhIP (dG-C8-PhIP) (44, 45) (46) . For the case of dG-C8-MeIQx, the internal standard was prepared by reaction of the N-acetoxy derivative of 3-[ 2 H 3 C]-MeIQx with dG. The adducts were purified by solid phase extraction, followed by HPLC purification (42, 43) .
Preparation of the DNA adducts
N-(Deoxyguanosin-8-yl)-AαC (dG-C8-AαC) (41), N-(deoxyguanosin-8-yl)-IQ (dG-C8-IQ), N-(deoxyguanosin-8-yl)-IQ, 5-(deoxyguanosin-N 2 -yl)-2-amino-3-methylimidazo[4,5- flquinoline (dG-N 2 -IQ), N-(deoxyguanosin-8-yl)-MeIQx (dG-C8-MeIQx), and 5-(deoxyguanosin-N 2 -yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (dG-N 2 -MeIQx)
Cell Isolation, Culture, and Metabolism Studies
Human liver samples were obtained from eight patients undergoing liver resection for primary or secondary hepatomas through the Biological Resource Center (CHRU Pontchaillou, Rennes, France). The research protocol was conducted under French legal guidelines and fulfilled the requirements of the local institutional ethics committee. This study was approved by the Institutional Review Board at the Wadsworth Center. Hepatocytes were isolated by a two-step collagenase perfusion procedure. The liver parenchymal cells were seeded in Petri dishes at a density of 3 × 10 6 viable cells/19.5 cm 2 dish, in 3 mL of Williams' medium with the following supplements: bovine serum albumin (1g/L), glutamine (2 mM), bovine insulin (5μg/mL), penicillin (10 U/mL), streptomycin (10 μg/mL) and fetal calf serum (10% v/v). The cell culture medium was renewed daily. After 36 h cell seeding, the media was replenished with cell media lacking fetal calf serum and hydrocortisone hemisuccinate (54 μM) was added. Then, 4-ABP or HAAs (10 μM) in DMSO (0.1% v/v) was added to the medium, and the cells were incubated for 3, 8 or 24 h. The incubations were terminated by collecting the culture medium. Adult male Sprague Dawley rats (200-250 g) were purchased from Janvier (Genest-Saint-Isle, France). Liver parenchymal cells were prepared and seeded at the same density, and treated with carcinogens as described above. No toxicity was observed with any compounds on the basis of the methylthiazoltetrazolium test for either human or rat hepatocytes.
The cells were scraped from the P60 Petri dishes with a spatula and combined with the cell media in Eppendorf tubes, followed by centrifugation. The supernatant containing the cell culture media was retrieved from the cellular pellets containing DNA, and both fractions were stored at −80 °C, prior to analyses. The cell culture media (5 μL) containing the equivalent of 11.2 ng of PhIP and its metabolites (50 pmol of PhIP) or the equivalent of 10.7 ng of MeIQx and its metabolites (50 pmol of MeIQx) were diluted with water (45 μL Ethoxyresorufin O-deethylation (EROD) associated with P450 1A1/2 activity was measured in cultured hepatocytes essentially as described by Burke and Mayer (47) . Methoxyresorufin O-demethylation (MROD) was used as a substrate for specific P450 1A2 activity (48) . The reaction rates were linear with time and proportional to protein concentration. Cellular protein content was estimated by the Bradford procedure (49) . Values (pmol/min/mg protein) are the mean ± SD of quadruplicate measurements.
Isolation and Enzymatic Digestion of DNA, and Solid Phase Enrichment of DNA Adducts
DNA was isolated from the cellular pellets by a chloroform/phenol extraction method (50) . The amount of DNA recovered from each carcinogen treatment was determined by UV spectroscopy, assuming a concentration of DNA (50 μg/mL) is equal to 1.0 absorbance unit at 260 nm. Isotopically labeled internal standards of each DNA adduct were added to the DNA recovered from the treated hepatocytes at a level of 1 adduct per 10 6 DNA bases. The DNA from the respective time points of the individually treated 4-ABP and HAA hepatocyte samples were then pooled. The enzymatic digestion conditions used for the hydrolysis of DNA (~2 -10 μg) in 5 mM Bis-Tris-HCl buffer (pH 7.1, 50 μL) employed DNAse I for 1.5 h, followed by incubation with nuclease P1 for 3 h, and then digested with alkaline phosphatase and phosphodiesterase for 18 h (45). These enzyme digestion conditions were shown to be highly efficient in the recovery of the dG-C8 adducts of PhIP, MeIQx, IQ, and 4-ABP from calf thymus DNA modified with these carcinogens (42) (43) (44) (45) 51, 52) . The DNA adducts were purified by solid phase extraction, using HyperSep ™ filter SpinTips, as previously described (52, 53) .
LC-ESI-MS/MS Measurements for Metabolites-
The analyses of 4-ABP and HAAs, and the metabolites of MeIQx and PhIP were performed with a NanoAcquity ™ UPLC system (Waters Corporation, Milford, MA) equipped with a Michrom C18 AQ column (0.3 × 150 mm, 3 μm particle size, Michrom Bioresources Inc., Auburn, CA), as previously described (54) . The analytes were separated by a gradient. The A solvent was 0.01% HCO 2 H in H 2 O, and the B solvent contained 0.01% HCO 2 H and 5% H 2 O in CH 3 CN. The flow rate was set at 6 μL/min, starting at 100% A increased by a linear gradient to 65% B in 13 min, and then to 100% B at 14 min holding for 1 min. The gradient was reversed to the 100% A over 1 min and at the same time the flow rate was increased from 6 μL/min to 10 μL/min. A post-run time of 3 min was required for re-equilibration. The back pressure of the column was 3,700 psi at the initial solvent conditions. The sample injection volume was 0.4 μL. The manipulation of UPLC system was done by MassLynx software (Waters Corp., Milford, MA).
The mass-spectral data were acquired on a Finnigan ™ Quantum Ultra Triple Stage Quadrupole MS (Thermo Fisher, San Jose, CA) and processed with Xcalibur version 2.07 software. Analyses were conducted in the positive ionization mode and employed an Advance CaptiveSpray ™ source from Michrom Bioresources Inc. (Auburn, CA). The spray voltage was set at 1400 V; the in-source fragmentation was 5 V; and the capillary temperature was 200 °C. There was no sheath or auxiliary gas. The peak widths (in Q1 and Q3) were set at 0. The dwell time for each transition was 10 ms. Argon was used as the collision gas and was set at 1.5 mTorr. Product ion spectra were acquired on the protonated molecules [M + H] + , scanning from m/z 50 to 250 or 500 at a scan speed of 500 amu/s using the same acquisition parameters as above. 3 Measurements for DNA Adducts-The DNA adduct analyses were conducted with an Agilent 1100 Series capillary LC system (Agilent Technologies, Palo Alto, CA) equipped with an Aquasil C18 column (0.32 × 250 mm) from Thermo Fisher (Bellafonte, PA). Samples (2 μL) were injected, and analytes were separated with a gradient. The solvent conditions were held at 100% A (solvent composition: 0.01% HCO 2 H and 10% CH 3 CN) for 2 min, followed by a linear gradient to 100% B (solvent composition: 95% CH 3 CN containing 0.01% HCO 2 H) over 30 min at a flow rate of 6 μL/min. The MS instrumentation was a linear quadrupole ion trap mass spectrometer (LTQ, Thermo Fisher, San Jose, CA), and Xcalibur version 2.07 software was used for data manipulations. The normalized collision energies were set at 32 and 40, and the isolation widths were set at 3.0 and 1.0 Da, respectively, for the MS 2 and MS 3 scan modes, for all adducts. The activation Q was set at 0.35 and the activation time was 10 ms, for both scan modes. Helium was used as the collision damping gas in the ion trap and was set at a pressure of 1 mTorr. One μscan was used for data acquisition. The automatic gain control settings were full MS target 30,000 and MS n target 10,000, and the maximum injection time was 10 ms.
LC-ESI/MS/MS
Calibration curves-Estimates of MeIQx and PhIP metabolites were done with external calibration curves using 50 pg of isotopically labeled parent compounds and 150 pg of isotopically labeled metabolites. The unlabeled metabolite calibrant levels ranged from 0.5 to 30-fold the amount of the internal standards. The calibration curves were fitted to a straight line (area of response of the metabolite/internal standard versus the amount of metabolite/internal standard) using ordinary least-squares with equal weightings. The coefficient of determination (r 2 ) values of the slopes exceeded 0.99.
Calibration curves were constructed with the stable, isotopically labeled DNA adducts set at 14.3 pg and a 6 point calibration curve with unlabeled DNA adducts was established with 0, 1.43 pg -143 pg of each adduct added to the DNA digest matrix (10 μg), following solid phase extraction. Assuming an average recovery of 10 μg of DNA (30 nmol of deoxynucleoside) from each hepatocyte incubation, the level of internal standard represented 10 adducts per 10 7 bases and the levels of unlabeled adduct ranged from 1 to 100 adducts per 10 7 bases The calibration curves were done in triplicate at each level, and the data were fitted to a straight line (area of response of the adduct/internal standard versus the amount of adduct/internal standard) using ordinary least-squares with equal weightings. The coefficient of determination (r 2 ) values of the slopes exceeded 0.98.
Results
4-ABP and HAA Metabolism in Human Hepatocytes
4-ABP, AαC, IQ, MeIQx, and PhIP undergo metabolic activation at the exocyclic amine group by cytochrome P450 enzymes to produce the genotoxic N-hydroxylated metabolites. These intermediates undergo esterification by phase II enzymes, including Nacetyltransferases (NATs) or sulfotransferases (SULTs), to produce electrophiles that react with DNA (19, 20, (56) (57) (58) . The structures of these carcinogens and their DNA adducts are shown in Figure 1 .
The kinetics of metabolism and DNA adduct formation of the carcinogens were determined following 3, 8 or 24 h of incubation. These time points were selected on the basis of our previous studies on PhIP and MeIQx (10 μM) with human hepatocytes, which showed that up to 97% of the doses underwent metabolism after 24 h incubation. The extent of metabolism was strongly correlated to the level of P4501A2 enzyme activity (37, 38) . The rates of metabolism of HAAs and 4-ABP were measured in hepatocyte preparations from two donors. The metabolism of HAAs was more rapid than that of 4-ABP (Figure 2 ). At the 24 h time point, 71 -98% of the doses of HAAs underwent metabolism, whereas 59 to 77% of the amount of 4-ABP underwent biotransformation. N-hydroxy-4-ABP was reported to undergo reduction to form 4-ABP at greater rates than the N-hydroxy-HAA substrates formed the parent HAAs, by an NADPH-dependent reductase, when employing rat or human microsomes, rat hepatocytes or human HepG2 cells (59) . This reductase activity could influence the relative amounts of 4-ABP or HAAs remaining in primary culture.
We previously characterized the major pathways of metabolism of MeIQx and PhIP in freshly cultured human and rat hepatocytes employing the 14 C-labelled HAAs as substrates (37, 38) . In this current study, we measured the amounts of the principal metabolites of MeIQx and PhIP produced by human hepatocytes, employing LC-ESI/MS/MS with stable, isotopically labeled internal standards for quantitative measurements. The metabolic pathways of MeIQx and PhIP are depicted in Figure 3 , and the kinetics of metabolite formation are shown in Figure 4 . The LC-ESI/MS/MS traces of MeIQx and PhIP metabolites (formed at T 24 h) and their product ion spectra are shown in Supporting Information, Figures S-1 and S-2. The findings on metabolite formation are consistent with our earlier studies that employed radiolabelled substrates (37, 38) . Both MeIQx and PhIP undergo N-oxidation by P450 1A2, to produce HONH-MeIQx and HONH-PhIP as principal oxidation products. These N-hydroxylated HAAs undergo conjugation with glucuronic acid to form HON-MeIQx-N 2 -Gl and HON-PhIP-N 2 -Gl. The isomeric glucuronide conjugate HONH-N3-PhIP is formed, but it occurs at ~10-fold lower levels than HON-PhIP-N 2 -Gl. P450 1A2 also mediates oxidation of the 8-CH 3 group of MeIQx, to produce the alcohol IQx-8-CH 2 OH and the carboxylic acid, IQx-8-COOH, as other prominent metabolites (60) . The phase II conjugation products MeIQx-N 2 -SO 3 H, MeIQx-N 2 -Gl and the isomeric Nglucuronide conjugates PhIP-N 2 -Gl and PhIP-N3-Gl were also formed, the latter PhIP-N-Gl metabolites were produced at considerably lower levels than the HON-PhIP-N-Gl metabolites.
We have also examined the metabolism of AαC in human hepatocytes, by LC-ESI/MS/MS, in positive and negative ionization modes (Supporting Information, Figure S-3 A and Figure  S-3 B) . There is evidence for the formation of two glucuronide conjugates of AαC; four glucuronide conjugates of ring-or N-oxidized AαC; and two sulfate conjugates of AαC. The elucidation of the sites of AαC oxidation and phase II conjugation requires further study.
Monitoring 4-ABP and HAA DNA Adduct Formation in Human Hepatocytes
The LTQ MS was employed at the MS 3 stage, to characterize and measure product ions of the aglycone adducts [BH 2 ] + . The LC-ESI/MS/MS 3 traces of DNA adducts formed in hepatocytes treated with carcinogens for 8 h are shown in Figure 5 . The dG-C8 DNA adducts of all carcinogens were readily identified. In addition, an isomeric dG-N 2 adduct of 4-ABP (tentatively assigned) and a minor 4-ABP adduct formed at the C8 atom with dA were detected (55, 56) . The dG-N 2 adducts of MeIQx and IQ were also identified. The LC-ESI/MS/MS 3 product ion spectra of the DNA adducts and the respective internal standards are shown in Supporting Information, Figure S-4 . The product ion spectra provide rich structural information about the structures of the adducts and corroborate their identities (45, 52, 53, 58) .
The kinetics of DNA adduct formation were investigated in human hepatocytes of 4 donors (Figure 6 ), including donors F and G, which were examined for the metabolism of MeIQx and PhIP. At the earliest time point measured (3 h), the amount of the dG-C8-AαC formed was far greater than the levels of DNA adducts formed by any of the other carcinogens. The levels of dG-C8-HAA adduct formation peaked between 3 and 8 h of incubation, whereas the amount of dG-C8-4-ABP adduct formation continued to increase during the course of the 24 h incubation, perhaps reflective of a slower rate of uptake or metabolism of 4-ABP in comparison to the HAAs (Figure 2 ). The kinetics of DNA adduct formation were similar in the hepatocytes of the 4 donors. The levels of dG-C8-HAA and dG-C8-4-ABP adduct formation at 24 h for the 8 donors are reported in Table 1 . The highest levels of adducts were consistently formed by AαC and 4-ABP, followed by PhIP, MeIQx and IQ.
4-ABP and HAA DNA Adduct Formation in Rat Hepatocytes
The kinetics of 4-ABP-and HAA-DNA adduct formation were also determined in hepatocytes isolated from 3 different rats (Figure 7) . The EROD activities ranged from 0.4 to 2.7 pmol resorufin/min/mg protein, and MROD activities ranged from 0.8 to 1.6 pmol resorufin/min/mg protein. These P450 enzyme activities were comparable, if not superior to the P450 enzyme activities measured in the hepatocytes of 3 human donors ( Table 1) .
The amounts of dG-C8-4-ABP ranged from 4.2 to 7.2 adducts per 10 6 bases following 24 h of incubation; these levels of adduct formation are similar to the amounts of dG-C8-4-ABP formed in human hepatocytes (Figure 4) . dG-C8-AαC was the second most abundant adduct formed: the levels ranged from 0.5 to 3.1 adducts per 10 6 bases at 24 h of incubation, followed by dG-C8-MeQx (0.1 -0.3 adducts per 10 6 bases/24 h), and then by dG-C8-PhIP (0.01 -0.02 adducts per 10 6 bases/24 h).
Discussion
Human hepatocytes are highly efficient in the bioactivation of 4-ABP and HAA and in ensuing DNA adduct formation. The highest levels of adducts were formed with AαC, followed by 4-ABP, with lesser but appreciable amounts of adducts formed with PhIP, MeIQx, and IQ. 4-ABP induces cancer of the urinary bladder, liver, and mammary gland in rodents (61, 62) , and 4-ABP is a recognized human urinary bladder carcinogen (2) . Cigarette smokers are at elevated risk for urinary bladder cancer, and the role of aromatic amines, including 4-ABP, as causal agents of this disease is well documented (2, 63, 64) . It is noteworthy that the amounts of AαC present in cigarette smoke are far greater than the levels of 4-ABP: up to 258 ng AαC is produced in mainstream smoke per cigarette versus 0.1 to 4.3 ng 4-ABP/cigarette (14, 15) . AαC causes liver and blood vessel tumors in CDF 1 mice (18) . AαC is a potent lacI transgene mutagen in the colon of C57BL/6 mice (Big Blue mouse) (65) , and it induces aberrant crypt foci, early biomarkers of tumors, in the colon of this species (66) ; although carcinogen bioassays with AαC have not been conducted in this mouse strain. We note that even though AαC forms DNA adducts at high levels in rat hepatocytes (Figure 6 ), AαC is not a hepatocarcinogen in the rat model (18) . HAAs and other genotoxicants form adducts in a number of tissues of experimental animals, where tumors do not develop during long-term feeding studies (67) . The development of cancer is complex and requires a number of steps, including multiple mutations, genetic alterations, and cell proliferation (18, 68) . AαC present in tobacco smoke may act as an initiating agent in the development of human cancer during chronic smoking, in which many other mutagens-carcinogens, tumor promoters, and factors stimulating tumor progression exist (18) .
The global DNA adduct formation and the genotoxicity of MeIQx, PhIP, AαC and 4-ABP in the hypoxanthine phosphoribosyl transferase (hprt) gene of Chinese hamster ovary cells (CHO) stably transfected with P450 1A1 or P450 1A2 and either NAT2*4 or NAT2*5B alleles were recently examined (53, (69) (70) (71) . On the basis of estimates of dG-C8-HAA and dG-C8-4-ABP adduct formation and assuming that these adducts are the principal genotoxic lesions, we estimate that one dG-C8-HAA or dG-C8-4-ABP adduct per 10 7 bases in the CHO genome induced about 1.5 hprt mutants for MeIQx; 2.5 hprt mutants for AαC, 2.8 hprt mutants for PhIP, and ~0.7 hprt mutants for 4-ABP per one million cells, at the dose concentrations of 1.5 μM (MeIQx and AαC), 1.2 μM (PhIP) and 2 μM (4-ABP) (53, (69) (70) (71) . The potential of dG-C8-HAA and dG-4-ABP adducts to induce mutations at the hprt locus appear similar; the different levels of mutation induced by these carcinogens in CHO cells were driven by the differing levels of adduct formation, which are dependent upon the levels of N-oxidation and ensuing activation of the N-hydroxylated metabolites by phase II enzymes. In our current study, the levels of 4-ABP and HAA adducts formed in human hepatocytes well exceed the threshold adduct levels that induced hprt mutations in CHO cells.
HAA-DNA adduct formation for MeIQx and PhIP was up to 100-fold greater in human hepatocytes than in rat hepatocytes (Figures 6 and 7) , whereas the levels of 4-ABP-DNA adducts were similar in hepatocytes of both species. Human and rat hepatocytes displayed comparable levels of MROD activity: a measure of P450 1A2 and the principal enzyme involved in N-oxidation of HAAs (72) . The discrepancy in MeIQx-and PhIP-DNA adduct formation between species can be explained, in part, by the different catalytic activities of human and rat P4501A2 orthologues towards these procarcinogens. The catalytic efficiency of human P450 1A2 is 11-and 19-fold superior than rat P450 1A2 in the N-oxidation of MeIQx and PhIP, respectively, whereas the catalytic efficiency of MROD is quite comparable for human and rat P450 1A2 (72) . MeIQx and PhIP are extensively metabolized in human hepatocyte preparations (>75% of the 10 μM dose); however, both carcinogens are poorly metabolized in rat hepatocytes, and a majority of the dose remains unmetabolized, even after 24 h (37,38). There are also interspecies differences in regioselectivity of the P450 1A2 oxidation of PhIP and MeIQx. Rat P4501A2 catalyzes oxidation at the heterocyclic rings of PhIP and MeIQx to produce detoxication products; N-oxidation products of both HAAs account for less than 2% of the dose in rat hepatocytes (37, 38) . In contrast to the rat P450 1A2 orthologue, the catalysis of ring oxidation products of PhIP and MeIQx, by human P450 1A2, is negligible (72, 73) , and a principal metabolic pathway for both HAAs in human hepatocytes occurs by P450 1A2-mediated N-oxidation (Figure 4 ) (37, 38) . In the case of 4-ABP, up to 23% of the dose (10 μM) was converted into Noxidation products in rat hepatocytes (74) . The DNA binding data show that both human and rat P450 1A2 orthologues efficiently carry out the N-oxidation of 4-ABP and comparable levels of DNA adducts are formed in hepatocytes of both species (Figures 6 and 7) .
The major pathways of metabolism of MeIQx and PhIP have been extensively characterized in rat and human hepatocytes (37, 38, 75, 76) , and in vivo of both species (40, 77) , but knowledge about the metabolism of AαC is limited. The metabolism of AαC was examined in the human liver tumor HepG2 cell line (78) ; however, these cells do not express P450 1A2 (79) and are devoid of UGTs (78), and thus, the AαC metabolites formed may not accurately reflect the biotransformation pathways that occur for AαC in humans. Recombinant human P450 1A2 enzyme does catalyze N-oxidation of the exocyclic amine group of AαC, as well as ring oxidation at the C3 and C6 atoms of the AαC heteronucleus (80, 81) . Both human and rodent uridine diphosphate-glucuronosyltransferases are involved in the detoxication of MeIQx and PhIP (40, 75, 77, 82) . There is also evidence for the formation of N-glucuronide conjugates of AαC in rodents (83) . Glutathione S-transfereases catalyze the detoxication of N-oxidized PhIP metabolites (84, 85) , but this family of enzymes has not been found to be involved in the detoxication of N-oxidized metabolites of MeIQx (84) AαC undergoes N-oxidation by human P450 1A2, as well as P450s 1A1 and 2C9/2C10, which are highly expressed in the colon and respiratory tract (80) . Moreover, human NAT1 and NAT2, and SULT1A1, which are expressed in liver and extrahepatic tissues, catalyze the binding of HONH-AαC to DNA (86, 87) . Thus, the potential for AαC to undergo metabolism and induce DNA damage in multiple organs that are in direct or indirect contact with tobacco smoke is great. Given the large amounts of AαC that arise in tobacco smoke (25, 26) and the elevated levels of AαC found in urine of smokers in comparison to nonsmokers (88) , studies investigating the potential role of AαC in the carcinogenicity of liver and gastrointestinal cancers associated with tobacco smoking (89) are warranted.
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